BioPorto A/S (BIOPOR.CO) Return on Equity (ROE)
Market Cap: $610.11M
Avg Volume: 369.91K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Return on Equity (ROE) Summary
BioPorto A/S's ROE measures the return generated on shareholders' equity:
- Annual: -93.63%
- Quarterly: -24.13%
- TTM: -83.62%
What is Return on Equity (ROE)?
Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.
Related Metrics
Other important metrics to assess BioPorto A/S's profitability include:
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: -82.14%
- Quarterly: -22.17%
- TTM: -69.24%
- ROA (Return on Assets) - measures the return generated on the company's assets:
- Annual: -62.72%
- Quarterly: -19.18%
- TTM: -56.29%
- Profit Margin - indicates the profitability of the company relative to its revenue:
- Annual: -181.95%
- Quarterly: -215.65%
- TTM: -175.62%
These metrics provide insights into BioPorto A/S's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROE
-93.63%
Quarterly ROE
-24.13%
TTM ROE
-83.62%
BioPorto A/S Historical ROE
Historical ROIC
Historical ROA
BioPorto A/S Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | ROE | ROIC | ROA | Profit Margin |
|---|---|---|---|---|
| 2023 | -93.63% | -82.14% | -62.72% | -181.95% |
| 2022 | -108.12% | -89.66% | -69.88% | -262.08% |
| 2021 | -124.26% | -98.45% | -70.29% | -235.48% |
| 2020 | -61.01% | -52.28% | -43.88% | -265.31% |
| 2019 | -275.03% | -232.39% | -163.16% | -261.60% |
| 2018 | -67.70% | -66.87% | -57.47% | -146.25% |
| 2017 | -57.51% | -55.57% | -49.15% | -128.18% |
| 2016 | -51.48% | -50.15% | -45.02% | -110.04% |
| 2015 | -24.12% | -23.61% | -21.91% | -52.65% |
| 2014 | -45.06% | -45.37% | -34.71% | -69.10% |
Related Metrics
Explore detailed financial metrics and analysis for BIOPOR.CO.